AntiBKV

· Memo Therapeutics AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AntiBKV, covering 2025-09-29 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients [Phase 2, Phase 3]

See pricing